Tennant Q2 2025 slides: Sales decline 4.5% but company reaffirms full-year guidance

Tennant Company (NYSE:TNC) reported a 4.5% organic sales decline and lower adjusted EPS in Q2 2025, leading to a 2.97% stock drop and continued trading near its 52-week low. Despite these challenging results, management reaffirmed its full-year guidance, citing strong order growth with a book-to-bill ratio above 1.0 and increasing adoption of autonomous cleaning solutions as key positive indicators. This maintained outlook reflects management's confidence in their strategic trajectory, though the market's negative reaction suggests investors are awaiting more concrete evidence of a turnaround.

Analysis

Tennant Company (TNC) reported challenging second-quarter 2025 results, characterized by a 4.5% organic sales decline to $318.6 million and a fall in adjusted EPS to $1.49 from $1.83 year-over-year. This performance, which follows a weak first quarter, prompted a 2.97% stock decline and pushed the shares closer to their 52-week low. The sales contraction was broad-based, with declines in the Americas (-5.5%), EMEA (-1.4%), and APAC (-5.0%), while profitability was squeezed by a 100 basis point drop in gross margin and a 170 basis point decrease in adjusted EBITDA margin to 16.0%. Management attributes the top-line weakness primarily to lapping a significant $26 million backlog-reduction benefit from Q2 2024. Despite these headwinds, several forward-looking indicators are positive. The company's order book grew 8% year-to-date, with a book-to-bill ratio exceeding 1.0, signaling potential for future revenue stabilization. Furthermore, strategic initiatives in high-growth areas are gaining traction, with its Autonomous Mobile Robot (AMR) portfolio now constituting 6% of net sales. In a significant display of confidence, management reaffirmed its full-year 2025 guidance, which projects a modest organic sales decline of 1.0% to 4.0% but anticipates slight EBITDA margin expansion. This suggests a strong belief that the second-half performance, propelled by a strong order book and new product launches, will offset the first-half softness.

Key Decisions for Investors

• Investors should closely monitor the conversion of the strong order book, which grew 8% year-to-date, into recognized revenue in the upcoming quarters to validate management's reaffirmed guidance.
• Pay close attention to the growth and margin contribution of the Autonomous Mobile Robot (AMR) segment, which now accounts for 6% of sales, as its performance is critical to the company's long-term growth narrative and ability to offset weakness in mature product lines.
• Given the stock is trading near its 52-week low and reflects significant market skepticism, investors might consider the current valuation an entry point if they believe in the H2 turnaround story, but should await tangible evidence of financial improvement in Q3.
• Assess the company's capital deployment, noting the balance between shareholder returns ($18 million in Q2) and strategic investments ($16 million in ERP modernization), which is supported by a low net leverage ratio of 0.66x.